Abvc Biopharma Inc (ABVC) - News Archive

In a remarkable turn of events for mental health treatment, ABVC BioPharma, Inc. (NASDAQ: ABVC), headquartered in Fremont, California, has made significant strides toward revolutionizing therapeutic modalities for menta...

The clinical-stage biopharmaceutical company, ABVC BioPharma Inc. (NASDAQ: ABVC), publicized a new global definitive licensing deal with OncoX, a dietary supplements specialist in oncology. The deal focuses on propellin...

In a significant development, ABVC BioPharma, a renowned clinical-stage biopharmaceutical company, has successfully executed a global licensing term sheet with OncoX BioPharma. This collaboration aims to encompass ABVC...

ABVC BioPharma, a clinical-stage biopharmaceutical company specializing in ophthalmology, CNS, and oncology/hematology, has announced a significant global licensing deal for its medical device, Vitargus. The company, al...

In a recent update, ABVC BioPharma, Inc. has announced its new direction in the fields of oncology and hematology, aiming to tap into the lucrative cancer market. The company, known for its development of therapeutic so...